 Foster Goss
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2025 | 1046 | 3.320 |
Why?
| | Documentation | 9 | 2022 | 191 | 1.810 |
Why?
| | Drug Hypersensitivity | 10 | 2025 | 90 | 1.790 |
Why?
| | Speech Recognition Software | 4 | 2020 | 11 | 1.770 |
Why?
| | Medical Errors | 3 | 2019 | 112 | 1.570 |
Why?
| | Hypersensitivity | 6 | 2025 | 257 | 1.310 |
Why?
| | Vocabulary, Controlled | 4 | 2018 | 47 | 1.110 |
Why?
| | Speech | 2 | 2019 | 70 | 1.080 |
Why?
| | Acetaminophen | 4 | 2023 | 266 | 1.040 |
Why?
| | Bupropion | 2 | 2023 | 45 | 1.000 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2022 | 250 | 0.970 |
Why?
| | Poisons | 2 | 2022 | 23 | 0.960 |
Why?
| | Analgesics, Non-Narcotic | 2 | 2023 | 124 | 0.910 |
Why?
| | Emergency Service, Hospital | 6 | 2021 | 2046 | 0.910 |
Why?
| | Natural Language Processing | 5 | 2018 | 94 | 0.800 |
Why?
| | Medical Order Entry Systems | 5 | 2025 | 43 | 0.780 |
Why?
| | Poisoning | 1 | 2022 | 116 | 0.730 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 362 | 0.610 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 163 | 0.610 |
Why?
| | Drug Prescriptions | 1 | 2021 | 243 | 0.610 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 223 | 0.600 |
Why?
| | Medical Records | 1 | 2018 | 174 | 0.560 |
Why?
| | Decision Trees | 4 | 2023 | 93 | 0.500 |
Why?
| | Firearms | 1 | 2022 | 376 | 0.500 |
Why?
| | Uterine Artery Embolization | 1 | 2014 | 7 | 0.460 |
Why?
| | Uterine Hemorrhage | 1 | 2014 | 33 | 0.450 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 27 | 0.450 |
Why?
| | Uterus | 1 | 2014 | 215 | 0.410 |
Why?
| | Lithium | 2 | 2023 | 43 | 0.400 |
Why?
| | Diphenhydramine | 2 | 2023 | 37 | 0.400 |
Why?
| | Health Personnel | 1 | 2019 | 701 | 0.400 |
Why?
| | Adverse Drug Reaction Reporting Systems | 4 | 2022 | 77 | 0.390 |
Why?
| | Medication Errors | 4 | 2025 | 95 | 0.390 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 48 | 0.380 |
Why?
| | Calcium Channel Blockers | 2 | 2023 | 167 | 0.380 |
Why?
| | Ticlopidine | 1 | 2012 | 52 | 0.370 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2012 | 140 | 0.360 |
Why?
| | Thiophenes | 1 | 2012 | 117 | 0.360 |
Why?
| | Humans | 40 | 2025 | 136765 | 0.360 |
Why?
| | Boston | 3 | 2020 | 91 | 0.340 |
Why?
| | Piperazines | 1 | 2012 | 350 | 0.320 |
Why?
| | Pilot Projects | 4 | 2023 | 1692 | 0.310 |
Why?
| | Algorithms | 4 | 2025 | 1689 | 0.310 |
Why?
| | Terminology as Topic | 3 | 2015 | 216 | 0.300 |
Why?
| | Machine Learning | 3 | 2023 | 487 | 0.300 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 462 | 0.290 |
Why?
| | Systematized Nomenclature of Medicine | 3 | 2018 | 13 | 0.280 |
Why?
| | Information Storage and Retrieval | 2 | 2021 | 117 | 0.270 |
Why?
| | Penicillins | 2 | 2025 | 58 | 0.260 |
Why?
| | Aspirin | 2 | 2022 | 387 | 0.250 |
Why?
| | Physicians | 3 | 2020 | 907 | 0.240 |
Why?
| | Medication Reconciliation | 1 | 2025 | 29 | 0.230 |
Why?
| | Medical History Taking | 1 | 2025 | 117 | 0.230 |
Why?
| | Cephalosporins | 1 | 2025 | 47 | 0.230 |
Why?
| | Food Hypersensitivity | 2 | 2017 | 183 | 0.210 |
Why?
| | Analgesics, Opioid | 2 | 2025 | 992 | 0.200 |
Why?
| | Support Vector Machine | 1 | 2022 | 38 | 0.190 |
Why?
| | Retrospective Studies | 7 | 2025 | 15504 | 0.180 |
Why?
| | Poison Control Centers | 1 | 2022 | 90 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2022 | 153 | 0.180 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2022 | 136 | 0.170 |
Why?
| | Medical Records Systems, Computerized | 2 | 2018 | 92 | 0.160 |
Why?
| | Workflow | 2 | 2019 | 165 | 0.160 |
Why?
| | Aged, 80 and over | 3 | 2022 | 7585 | 0.160 |
Why?
| | Middle Aged | 8 | 2025 | 33228 | 0.160 |
Why?
| | Massive Hepatic Necrosis | 1 | 2019 | 3 | 0.160 |
Why?
| | Seizures | 1 | 2023 | 425 | 0.160 |
Why?
| | Biological Ontologies | 1 | 2019 | 20 | 0.160 |
Why?
| | Adult | 8 | 2025 | 37631 | 0.160 |
Why?
| | Hepatitis A | 1 | 2019 | 26 | 0.160 |
Why?
| | Allergens | 5 | 2022 | 408 | 0.150 |
Why?
| | Speech Perception | 1 | 2020 | 82 | 0.150 |
Why?
| | Community Health Planning | 1 | 2018 | 43 | 0.150 |
Why?
| | Aged | 5 | 2025 | 23794 | 0.150 |
Why?
| | Clinical Audit | 1 | 2018 | 13 | 0.150 |
Why?
| | Metformin | 1 | 2022 | 330 | 0.150 |
Why?
| | Travel | 1 | 2019 | 130 | 0.140 |
Why?
| | Datasets as Topic | 1 | 2018 | 119 | 0.140 |
Why?
| | Female | 15 | 2025 | 72795 | 0.140 |
Why?
| | Drug Therapy, Computer-Assisted | 2 | 2015 | 11 | 0.130 |
Why?
| | Linguistics | 1 | 2017 | 27 | 0.130 |
Why?
| | Perception | 1 | 2019 | 359 | 0.130 |
Why?
| | Models, Theoretical | 2 | 2020 | 575 | 0.130 |
Why?
| | Consensus | 1 | 2019 | 678 | 0.120 |
Why?
| | Pharmacovigilance | 1 | 2015 | 23 | 0.120 |
Why?
| | Anaphylaxis | 1 | 2017 | 105 | 0.120 |
Why?
| | Male | 13 | 2025 | 67311 | 0.120 |
Why?
| | Databases as Topic | 1 | 2015 | 67 | 0.120 |
Why?
| | Word Processing | 1 | 2015 | 2 | 0.120 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5423 | 0.120 |
Why?
| | United States | 6 | 2023 | 14690 | 0.120 |
Why?
| | Clinical Alarms | 1 | 2015 | 10 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2019 | 539 | 0.120 |
Why?
| | Data Accuracy | 1 | 2015 | 65 | 0.110 |
Why?
| | User-Computer Interface | 3 | 2025 | 159 | 0.110 |
Why?
| | Physician's Role | 1 | 2016 | 211 | 0.110 |
Why?
| | Social Media | 1 | 2016 | 157 | 0.100 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 322 | 0.100 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1163 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 98 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 159 | 0.100 |
Why?
| | Prasugrel Hydrochloride | 1 | 2012 | 22 | 0.100 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2012 | 24 | 0.100 |
Why?
| | Incidence | 2 | 2016 | 2792 | 0.100 |
Why?
| | Microcomputers | 1 | 2012 | 16 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2060 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2022 | 6032 | 0.090 |
Why?
| | Young Adult | 2 | 2022 | 13127 | 0.080 |
Why?
| | Emergency Medicine | 1 | 2012 | 226 | 0.080 |
Why?
| | Infant | 1 | 2022 | 9395 | 0.070 |
Why?
| | Colorado | 1 | 2018 | 4515 | 0.070 |
Why?
| | Adolescent | 3 | 2022 | 21382 | 0.070 |
Why?
| | Massachusetts | 2 | 2020 | 171 | 0.070 |
Why?
| | Child, Preschool | 1 | 2022 | 10997 | 0.070 |
Why?
| | Reference Standards | 2 | 2019 | 186 | 0.070 |
Why?
| | Opioid-Related Disorders | 1 | 2015 | 509 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5742 | 0.060 |
Why?
| | Patient Care Team | 1 | 2012 | 626 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2822 | 0.060 |
Why?
| | Prevalence | 3 | 2018 | 2710 | 0.060 |
Why?
| | Child | 2 | 2022 | 21819 | 0.060 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5106 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 3432 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1283 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2014 | 10745 | 0.040 |
Why?
| | Eating | 1 | 2022 | 379 | 0.040 |
Why?
| | Peru | 1 | 2019 | 58 | 0.040 |
Why?
| | Hypersensitivity, Delayed | 1 | 2018 | 28 | 0.040 |
Why?
| | Hypersensitivity, Immediate | 1 | 2018 | 44 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 303 | 0.040 |
Why?
| | Radioallergosorbent Test | 1 | 2017 | 3 | 0.030 |
Why?
| | Shellfish | 1 | 2017 | 6 | 0.030 |
Why?
| | Musculoskeletal Pain | 1 | 2016 | 36 | 0.030 |
Why?
| | Data Mining | 1 | 2017 | 116 | 0.030 |
Why?
| | Exanthema | 1 | 2016 | 78 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 342 | 0.030 |
Why?
| | Meaningful Use | 1 | 2015 | 12 | 0.030 |
Why?
| | Publishing | 1 | 2017 | 145 | 0.030 |
Why?
| | Utilization Review | 1 | 2015 | 36 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 934 | 0.030 |
Why?
| | Risk | 1 | 2017 | 908 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 407 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1282 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 179 | 0.030 |
Why?
| | Language | 1 | 2017 | 292 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 4013 | 0.030 |
Why?
| | Medication Systems, Hospital | 1 | 2012 | 9 | 0.030 |
Why?
| | China | 1 | 2013 | 216 | 0.020 |
Why?
| | Population Surveillance | 1 | 2016 | 474 | 0.020 |
Why?
| | Time and Motion Studies | 1 | 2012 | 25 | 0.020 |
Why?
| | Clinical Decision-Making | 1 | 2015 | 319 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1351 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2012 | 255 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2667 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2182 | 0.020 |
Why?
| | Risk Factors | 1 | 2015 | 10325 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 7572 | 0.010 |
Why?
|
|
Goss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|